Development of leptomeningeal carcinomatosis during a marked response of brain metastases to pembrolizumab in a patient with non-small-cell lung cancer

K. Otsubo; N. Seki; Y. Nakanishi; I. Okamoto

doi:10.1093/annonc/mdx700

Development of leptomeningeal carcinomatosis during a marked response of brain metastases to pembrolizumab in a patient with non-small-cell lung cancer

K. Otsubo
, N. Seki
, Y. Nakanishi
, I. Okamoto

がんセンター

研究成果: ジャーナルへの寄稿 › レター › 査読

4 被引用数 (Scopus)

本文言語	英語
ページ（範囲）	780-781
ページ数	2
ジャーナル	Annals of Oncology
巻	29
号	3
DOI	https://doi.org/10.1093/annonc/mdx700
出版ステータス	出版済み - 3月 1 2018

UN SDG

この成果は、次の持続可能な開発目標に貢献しています

SDG 3 すべての人に健康と福祉を

!!!All Science Journal Classification (ASJC) codes

血液学
腫瘍学

文献へのアクセス

10.1093/annonc/mdx700

他のファイルとリンク

引用スタイル

@article{10fd73b98c92488f8961c57f8880780e,

title = "Development of leptomeningeal carcinomatosis during a marked response of brain metastases to pembrolizumab in a patient with non-small-cell lung cancer",

author = "K. Otsubo and N. Seki and Y. Nakanishi and I. Okamoto",

year = "2018",

month = mar,

day = "1",

doi = "10.1093/annonc/mdx700",

language = "English",

volume = "29",

pages = "780--781",

journal = "Annals of Oncology",

issn = "0923-7534",

publisher = "Elsevier Ltd",

number = "3",

}

TY - JOUR

T1 - Development of leptomeningeal carcinomatosis during a marked response of brain metastases to pembrolizumab in a patient with non-small-cell lung cancer

AU - Otsubo, K.

AU - Seki, N.

AU - Nakanishi, Y.

AU - Okamoto, I.

PY - 2018/3/1

Y1 - 2018/3/1

UR - https://www.scopus.com/pages/publications/85046087105

UR - https://www.scopus.com/pages/publications/85046087105#tab=citedBy

U2 - 10.1093/annonc/mdx700

DO - 10.1093/annonc/mdx700

M3 - Letter

C2 - 29088405

AN - SCOPUS:85046087105

SN - 0923-7534

VL - 29

SP - 780

EP - 781

JO - Annals of Oncology

JF - Annals of Oncology

IS - 3

ER -